Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer

Harder, J.; Ihorst, G.; Heinemann, V.; Hofheinz, R.; Moehler, M.; Buechler, P.; Kloeppel, G.; Roecken, C.; Bitzer, M.; Boeck, S.; Endlicher, E.; Reinacher-Schick, A.; Schmoor, C.; Geissler, M.

dc.contributor.author	Bitzer, Michael
dc.date.accessioned	2014-05-12T15:12:46Z
dc.date.available	2014-05-12T15:12:46Z
dc.date.issued	2012
dc.identifier.issn	0007-0920
dc.identifier.uri	http://hdl.handle.net/10900/52794
dc.language.iso	en	de_DE
dc.publisher	Nature Publishing Group	de_DE
dc.relation.uri	http://dx.doi.org/10.1038/bjc.2012.18	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Multicentre phase II trial of trastuzumab and capecitabine in patients with HER2 overexpressing metastatic pancreatic cancer	de_DE
dc.type	Article	de_DE
utue.quellen.id	20140226071329_02920	de_DE
utue.publikation.seiten	1033-1038	de_DE
utue.personen.roh	Harder, J.
utue.personen.roh	Ihorst, G.
utue.personen.roh	Heinemann, V.
utue.personen.roh	Hofheinz, R.
utue.personen.roh	Moehler, M.
utue.personen.roh	Buechler, P.
utue.personen.roh	Kloeppel, G.
utue.personen.roh	Roecken, C.
utue.personen.roh	Bitzer, M.
utue.personen.roh	Boeck, S.
utue.personen.roh	Endlicher, E.
utue.personen.roh	Reinacher-Schick, A.
utue.personen.roh	Schmoor, C.
utue.personen.roh	Geissler, M.
dcterms.isPartOf.ZSTitelID	British Journal of Cancer	de_DE
dcterms.isPartOf.ZS-Issue	6	de_DE
dcterms.isPartOf.ZS-Volume	106	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE